Welcome to our dedicated page for Haleon news (Ticker: HLN), a resource for investors and traders seeking the latest updates and insights on Haleon stock.
Haleon plc (HLN) generates a steady stream of news as a global consumer health company with a portfolio that spans Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. This news page aggregates coverage of Haleon’s brand activity, partnerships, research collaborations and corporate announcements, giving readers a single place to review the latest developments affecting the company and its well-known brands such as Advil, Centrum, Sensodyne, Voltaren and TUMS.
Recent news releases highlight how Haleon activates its brands through consumer campaigns and partnerships. TUMS has featured in promotions tied to major football events, including sweepstakes and themed games with partners like DraftKings and creator Eric Decker (Airrack), emphasising fast-acting relief from occasional heartburn during food-focused occasions. Other updates showcase product and packaging initiatives, such as the use of bio-based materials in the nasal spray pump used with Haleon’s Otrivin brand through a collaboration with Aptar Pharma.
Haleon’s news flow also reflects its focus on science and research. Announcements include the groundbreaking of a Global Oral Health Innovation Centre in Weybridge to act as an R&D hub for oral health, participation as the central industry partner in a UK-wide doctoral training programme on oral health, and a collaboration with Brightseed to use the Forager AI platform for discovering plant-based small molecules with potential health benefits.
Corporate and strategic updates appear alongside brand stories, including changes to Haleon’s operating model, leadership appointments and digital initiatives such as adopting Salesforce Life Sciences Cloud for Customer Engagement. Investors and observers can use this page to follow how Haleon’s category strategy, research focus and brand activations are reflected in its public announcements over time.
Excedrin has launched the Head Care Club, a program designed to support everyday head health with routines from Emmy Award-winning choreographer Derek Hough. Research indicates that 70% of those experiencing migraines report a negative impact on their quality of life. The program promotes a holistic approach, encouraging proactive measures beyond just treating migraine attacks.
The new Head Care product line includes a daily dietary supplement and nutrient mixes aimed at improving head health. It emphasizes the need for mindfulness, nutrition, and movement to manage headaches and migraines effectively. Dr. Deena Kuruvilla, a neurologist, supports these methods, highlighting their potential benefits for overall brain health. Excedrin aims to enhance well-being via small lifestyle adjustments, reflecting its commitment to comprehensive headache management.
Haleon plc announced the redemption of its total outstanding $300 million Callable Floating Rate Senior Notes due 2024 by its subsidiary, GSK Consumer Healthcare Capital US LLC. The redemption is set for March 24, 2023, at a price equal to 100% of the principal amount plus any accrued interest. All noteholders will receive a notice of redemption from the trustee, Deutsche Bank Trust Company Americas, and the notes must be surrendered to collect the redemption price. This move underlines Haleon's financial strategy as it manages its debt obligations.
Haleon plc (LSE: HLN, NYSE: HLN) announced the expiration and final results of its exchange offers for seven series of unregistered notes issued by GSK Consumer Healthcare Capital. The offers, launched on September 29, 2022, expired on October 28, 2022. The Exchange Notes, which have been registered under the Securities Act, will replace the Original Notes. Settlement is expected on November 2, 2022. The primary aim was to provide holders of Original Notes with registered securities, eliminating prior transfer restrictions.
Haleon and Microsoft have partnered to enhance health product accessibility for individuals who are blind or have low vision. Launched on World Sight Day, the collaboration improves the Microsoft Seeing AI app, enabling detailed audio narrations for over 1,500 Haleon products across the U.S. and U.K. Users can scan barcodes to receive crucial information about product name, ingredients, and usage. This initiative aims to empower users in managing their health independently. Haleon also introduced its Health Inclusivity Index, aiming to enhance global health inclusivity.
Haleon plc (LSE: HLN, NYSE: HLN) announced the start of exchange offers for seven series of outstanding unregistered notes from GSK Consumer Healthcare Capital. The offers aim to exchange these unregistered notes for registered notes under the Securities Act, expected to be listed on the NYSE. The exchange period ends at 5:00 p.m. (Eastern time) on October 28, 2022, with settlement anticipated on November 2, 2022. A registration statement related to the exchange notes was filed with the SEC on the same date.
New results from the COSMOS-Mind study indicate that participants taking Centrum Silver exhibited significant improvements in cognitive function compared to those on placebo. This study, involving over 2,000 older adults, highlights the potential benefits of multivitamin supplementation in addressing cognitive decline, a major concern as aging populations grow. The findings suggest that Centrum Silver could enhance memory and executive function, stressing its importance for healthy aging. The detailed report is available in the Alzheimer & Dementia Journal.
Nicorette has launched SmokeLess Break Beats, a unique music therapy initiative aimed at supporting smokers in their cessation journey. Developed with Berklee Music and Health Institute, the program features eight original tracks designed to promote relaxation, focus, and confidence. Available for free on Spotify, these playlists serve as behavioral tools during typical smoke breaks. The initiative underscores the science behind music's ability to reduce cravings and enhance psychological well-being, increasing the effectiveness of Nicotine Replacement Therapy by up to 70%.
FAQ
What is the current stock price of Haleon (HLN)?
What is the market cap of Haleon (HLN)?
